Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT06101173

Completed

A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

Poliomyelitis
NCT04072497

Completed

A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years

Herpes Zoster
NCT04560881

Completed

Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

COVID-19 Virus Infection
NCT01051661

Completed

Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age

Influenza
NCT00481767

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.

Human Papillomavirus (HPV) Infection
NCT01513551

Completed

The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)

Pneumococcal Infections
NCT01865968

Completed

Comparison of Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines in Young Adults

Hepatitis A
NCT01427309

Completed

A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults

Influenza
NCT02152709

Completed

Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine

Hepatitis B
NCT06125691

Completed

Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults

Influenza, Human
NCT06908096

Recruiting

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

EBV | Epstein-Barr Virus Infection | Infectious Mononucleosis | Mono
NCT06771479

Recruiting

A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine

Monkeypox
NCT05654467

Recruiting

Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama

Poliomyelitis
NCT05644184

Recruiting

Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

Poliomyelitis
NCT05077137

Recruiting

A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy (TdVax)

Melanoma
NCT07342257

Completed

SYN023 With Rabies Vaccine in Healthy Pediatric Subjects

Rabies Post-exposure Prophylaxis
NCT06524947

Active, not recruiting

Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)

Acute Gastroenteropathy Due to Norovirus
NCT05079217

Active, not recruiting

Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19

COVID-19
NCT01864174

Completed

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus
NCT03460743

Completed

Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.

Influenza, Human
NCT00493324

Completed

Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis

Chronic Plaque Psoriasis
NCT00697567

Completed

Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant

Prophylaxis Herpes Simplex
NCT05006794

Active, not recruiting

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies

Solid Malignancies
NCT02997410

Unknown

Ozone Therapy for Masticatory Muscle Pain (OTMMP) (OTMMP)

Temporomandibular Joint Disorders | Orofacial Pain
NCT05565924

Completed

Alter-G Training on Gait and Balance in Diabetic Neuropathy Patients

Diabetic Peripheral Neuropathy
NCT04798001

Recruiting

Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults

Covid19
NCT00848991

Completed

Comparison of Propofol to Precedex With Propofol for Emergence and Recovery in Patients Having Craniotomy Surgery

Cranitomy Surgery
NCT03196102

Completed

Evaluation of a Brief Tobacco Intervention in the US Military

Tobacco Use | Tobacco Smoking | Nicotine Dependence | Smoking, Hookah | Smoking, Cigar | Smoking, Pipe
NCT05876377

Active, not recruiting

Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data

COVID-19 | SARS-CoV-2 | Post-Acute COVID-19 Syndrome
NCT06314659

Active, not recruiting

Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months

Healthy Population
NCT04239313

Completed

A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

Tuberculosis
NCT01430689

Completed

Maternal Flu Vaccine Trial in Bamako, Mali

Influenza
NCT00045227

Completed

Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer

Prostate Cancer
NCT06674811

Recruiting

Biomarkers of Resiliency In Childhood Cancer Surgery (BRICCS)

Sarcoma | Neuroblastoma | Pediatric Cancer | Wilms Tumor and Other Childhood Kidney Tumors | Childhood Soft Tissue Sarcoma | Childhood Malignant Liver Neoplasm | Childhood Bone Sarcoma | Childhood Malignant Intestinal Neoplasm | Childhood Malignant Lung Neoplasm | Childhood Malignant Ovarian Neoplasm
NCT06493929

Not yet recruiting

Mechanical Power As a Predictor for Weaning in Chronic Obstructive Pulmonary Disease Patients :Prospective Cohort Study.

Mechanical Power
NCT06345560

Recruiting

Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study

Contraception
NCT02956382

Completed

Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma

Relapsed Follicular Lymphoma | Refractory Follicular Lymphoma
NCT03053440

Completed

A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM) (ASPEN)

Waldenström's Macroglobulinemia
NCT04382586

Completed

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

COVID-19 | COVID-19 Pulmonary Complications
NCT04780659

Completed

COVID-19 Vaccination of Immunodeficient Persons (COVAXID) (COVAXID)

Covid19
NCT00953524

Completed

A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

Influenza | Swine-origin A/H1N1 Influenza
NCT06624839

Recruiting

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV (PROTECT)

HIV | Human Papilloma Virus | Anal Dysplasia
NCT06181656

Recruiting

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

Esophageal Cancer | Chemoradiation | Lymphopenia | Pneumococcal Vaccine
NCT06141369

Recruiting

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Medullary Thyroid Cancer | Pancreatic Neuroendocrine Tumor | Adrenal Cortical Carcinoma | Thymic Neuroendocrine Carcinoma
NCT05334706

Recruiting

A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV) (RIFT-HPV)

Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III) | Human Papillomavirus (HPV) Infections | High-risk HPV | HPV-16/ 18
NCT05164731

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

SARS-CoV2 Infection
NCT05156398

Recruiting

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Migraine
NCT04397926

Recruiting

Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer

Non Small Cell Lung Cancer
NCT04380623

Recruiting

A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families

Parents | HPV-Related Carcinoma | Human Papilloma Virus | Vaccine Refusal | Program, Communication
NCT05575492

Completed

A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age

Cytomegalovirus

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations